Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ALIM > SEC Filings for ALIM > Form 8-K on 1-May-2013All Recent SEC Filings

Show all filings for ALIMERA SCIENCES INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ALIMERA SCIENCES INC


1-May-2013

Other Events, Financial Statements and Exhibits


Item 8.01. Other Events.
On May 1, 2013, Alimera Sciences, Inc. (the Company) issued a press release announcing that its recent resubmission of its New Drug Application (NDA) for ILUVIENŽ has been acknowledged as received by the U.S. Food and Drug Administration (FDA) as a class 2 response to the FDA's November 2011 letter, and that a Prescription Drug User Fee Act (PDUFA) goal date of October 17, 2013 has been set. The PDUFA date is the date by which the Company can reasonably expect to have received the FDA's decision with respect to the NDA. A copy of the press release is attached as Exhibit 99.1 hereto and is incorporated by reference herein.




Item 9.01. Financial Statements and Exhibits.
(d) Exhibits

Exhibit No. Description
99.1 Press Release of Alimera Sciences, Inc. dated May 1, 2013


  Add ALIM to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ALIM - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.